Cambridge Investment Research Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-8,923
| Closed | -$243K | – | 3289 |
|
|
2023
Q3 | $243K | Sell |
8,923
-146
| -2% | -$3.98K | ﹤0.01% | 2666 |
|
|
2023
Q2 | $286K | Buy |
9,069
+382
| +4% | +$12K | ﹤0.01% | 2567 |
|
|
2023
Q1 | $236K | Sell |
8,687
-1,381
| -14% | -$37.5K | ﹤0.01% | 2683 |
|
|
2022
Q4 | $306K | Sell |
10,068
-1,137
| -10% | -$34.6K | ﹤0.01% | 2418 |
|
|
2022
Q3 | $338K | Sell |
11,205
-172
| -2% | -$5.19K | ﹤0.01% | 2269 |
|
|
2022
Q2 | $315K | Sell |
11,377
-410
| -3% | -$11.4K | ﹤0.01% | 2340 |
|
|
2022
Q1 | $397K | Buy |
11,787
+778
| +7% | +$26.2K | ﹤0.01% | 2299 |
|
|
2021
Q4 | $465K | Sell |
11,009
-6,827
| -38% | -$288K | ﹤0.01% | 2161 |
|
|
2021
Q3 | $812K | Sell |
17,836
-231
| -1% | -$10.5K | ﹤0.01% | 1693 |
|
|
2021
Q2 | $884K | Buy |
18,067
+1,383
| +8% | +$67.7K | ﹤0.01% | 1619 |
|
|
2021
Q1 | $839K | Buy |
16,684
+5,963
| +56% | +$300K | ﹤0.01% | 1555 |
|
|
2020
Q4 | $549K | Buy |
+10,721
| New | +$549K | ﹤0.01% | 1710 |
|
|
2016
Q1 | – | Sell |
-7,792
| Closed | -$247K | – | 1651 |
|
|
2015
Q4 | $247K | Sell |
7,792
-459
| -6% | -$14.6K | 0.01% | 1229 |
|
|
2015
Q3 | $230K | Buy |
+8,251
| New | +$230K | 0.01% | 1176 |
|